banner
ABBV image

AbbVie Inc.

ABBV

189.495

USD
+3.44
(+1.85%)
Day's range
187.635
191.32
52 wk Range
153.58
218.66

ABBV Income Statement

Period EndingDec 31, 2009Dec 31, 2010Dec 31, 2011Dec 31, 2012Dec 31, 2013Dec 31, 2014Dec 31, 2015Dec 31, 2016Dec 31, 2017Dec 31, 2018Dec 31, 2019Dec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024
Total Revenue14,214,196,00015,638,000,00017,443,951,00018,380,000,00018,790,000,00019,960,000,00022,859,000,00025,638,000,00028,216,000,00032,753,000,00033,266,000,00045,804,000,00056,197,000,00058,054,000,00054,318,000,00056,334,000,000
Cost of Revenue4,056,390,0004,293,000,0004,639,393,0004,508,000,0004,581,000,0004,426,000,0004,500,000,0005,833,000,0007,040,000,0007,718,000,0007,439,000,00015,387,000,00017,446,000,00017,414,000,00020,415,000,00016,904,000,000
Gross Profit10,157,806,00011,345,000,00012,804,558,00013,872,000,00014,209,000,00015,534,000,00018,359,000,00019,805,000,00021,176,000,00025,035,000,00025,827,000,00030,417,000,00038,751,000,00040,640,000,00033,903,000,00039,430,000,000
Gross Profit Margin0.7150.7250.7340.7550.7560.7780.8030.7720.750.7640.7760.6640.690.70.6240.7
R&D Expenses1,707,440,0002,495,000,0002,617,506,0002,778,000,0002,855,000,0003,297,000,0004,285,000,0004,366,000,0004,982,000,00010,329,000,0006,407,000,0006,557,000,0007,084,000,0006,510,000,0008,453,000,00012,791,000,000
General & Administrative Expenses3,348,572,0003,820,000,0005,893,820,0004,989,000,0005,352,000,0007,724,000,0006,387,000,0005,855,000,0006,275,000,0007,399,000,0005,842,000,0009,499,000,00010,249,000,00013,260,000,00010,704,000,0000
Selling & Marketing Expenses000506,000,000626,000,000665,000,000704,000,000764,000,000846,000,0001,100,000,0001,100,000,0001,800,000,0002,100,000,0002,000,000,0002,200,000,0000
SG&A Expenses3,348,572,0003,820,000,0005,893,820,0004,989,000,0005,352,000,0007,724,000,0006,387,000,0005,855,000,0006,275,000,0007,399,000,0006,942,000,00011,299,000,00012,349,000,00015,260,000,00012,872,000,00014,752,000,000
Other Expenses061,000,00009,000,0001,000,00027,000,000-13,000,000-232,000,000-513,000,000-18,000,000-890,000,000-5,614,000,000432,000,00056,000,00002,750,000,000
Total Operating Expenses5,056,012,0006,315,000,0008,511,326,0007,767,000,0008,207,000,00011,771,000,00010,672,000,00010,221,000,00011,257,000,00018,228,000,00012,459,000,00017,856,000,00019,865,000,00021,826,000,00021,146,000,00030,293,000,000
Total Costs & Expenses9,112,402,00010,608,000,00013,150,719,00012,571,000,00013,126,000,00016,549,000,00015,322,000,00016,298,000,00018,671,000,00026,370,000,00020,283,000,00034,441,000,00038,273,000,00039,937,000,00041,561,000,00047,197,000,000
Interest Income028,000,00020,000,00020,000,00021,000,00038,000,00033,000,00082,000,000146,000,000204,000,000275,000,000174,000,00039,000,000186,000,000540,000,000648,000,000
Interest Expense000104,000,000299,000,000429,000,000719,000,0001,047,000,0001,150,000,0001,348,000,0001,784,000,0002,454,000,0002,423,000,0002,230,000,0002,224,000,0002,808,000,000
Depreciation & Amortization697,492,0001,184,000,0001,272,194,0001,150,000,000897,000,000786,000,000836,000,0001,189,000,0001,501,000,0001,765,000,0002,017,000,0006,471,000,0008,521,000,0008,467,000,0008,698,000,0008,386,000,000
EBITDA6,647,809,0006,020,000,0004,940,721,0006,979,000,0006,914,000,0006,286,000,0009,692,000,00010,812,000,00011,774,000,00013,688,000,00016,264,000,00021,148,000,00028,280,000,00031,424,000,00017,308,000,00014,910,000,000
EBITDA Margin0.4680.3850.2830.380.3680.3150.4240.4220.4170.4180.4890.4620.5030.5410.3190.265
Operating Income4,931,794,0004,717,000,0003,620,732,0006,622,000,0005,664,000,0003,411,000,0007,537,000,0009,340,000,0009,545,000,0006,383,000,00012,983,000,00011,363,000,00017,924,000,00018,117,000,00012,757,000,0009,137,000,000
Operating Income Margin0.3470.3020.2080.360.3010.1710.330.3640.3380.1950.390.2480.3190.3120.2350.162
Total Other Income/Expenses (Net)806,523,000-319,983,00048,527,000-92,000,000-332,000,000-1,042,000,000-892,000,000-1,456,000,000-1,818,000,000-1,186,000,000-4,557,000,000-7,965,000,000-4,935,000,000-4,640,000,000-6,507,000,000-5,421,000,000
Income Before Tax5,950,317,0004,836,000,0003,668,527,0005,725,000,0005,332,000,0002,369,000,0006,645,000,0007,884,000,0007,727,000,0005,197,000,0008,426,000,0003,398,000,00012,989,000,00013,477,000,0006,250,000,0003,716,000,000
Pre-Tax Income Margin0.4190.3090.210.3110.2840.1190.2910.3080.2740.1590.2530.0740.2310.2320.1150.066
Income Tax Expense1,313,802,000658,000,000235,399,000450,000,0001,204,000,000595,000,0001,501,000,0001,931,000,0002,418,000,000490,000,000544,000,0001,224,000,0001,440,000,0001,632,000,0001,377,000,000-570,000,000
Net Income4,636,515,0004,178,000,0003,433,128,0005,275,000,0004,128,000,0001,774,000,0005,144,000,0005,953,000,0005,309,000,0005,687,000,0007,882,000,0004,616,000,00011,542,000,00011,836,000,0004,863,000,0004,278,000,000
Net Income Margin0.3260.2670.1970.2870.220.0890.2250.2320.1880.1740.2370.1010.2050.2040.090.076
Earnings Per Share (EPS)2.872.592.123.352.581.113.153.653.313.695.32.736.486.652.732.42
Diluted Earnings Per Share (EPS)2.852.572.113.352.561.13.133.633.33.685.282.726.456.632.722.39
Weighted Average Shares Outstanding1,616,000,0001,616,000,0001,616,000,0001,577,000,0001,589,000,0001,595,000,0001,625,000,0001,622,000,0001,596,000,0001,541,000,0001,481,000,0001,667,000,0001,770,000,0001,771,000,0001,768,000,0001,765,256,986
Weighted Average Shares Outstanding (Diluted)1,625,000,0001,625,000,0001,625,000,0001,577,000,0001,604,000,0001,610,000,0001,637,000,0001,631,000,0001,603,000,0001,546,000,0001,484,000,0001,673,000,0001,777,000,0001,778,000,0001,773,000,0001,773,000,000